The Evaluation of the Effect of Mesenchymal Stem Cells on the Immune System of Patients With ALS
Status:
Recruiting
Trial end date:
2023-02-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the safety of intrathecal administration of
Wharton's Jelly Mesenchymal Stem Cells (WJMSC) and the impact on the immune system of
patients with Amyotrophic Lateral Sclerosis.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Polski Bank Komorek Macierzystych JSC (PBKM)
Collaborators:
National Center for Research and Development, Poland The National Centre for Research and Development